 human recombin dna-deriv antihemophil factor factor viii treatment hemophilia recombin factor viii studi group background current treatment hemophilia hereditari disord male reli plasma-deriv factor viii concentr safeti efficaci recombin factor viii prepar treatment disord method investig stage pharmacokinet plasma-deriv recombin factor viii efficaci recombin factor viii home therapi efficaci major surgic procedur hemorrhag total subject hemophilia investig result vivo recoveri elimin half-liv recombin factor viii plasma-deriv factor viii seventy-six subject home-treat program recombin factor viii day median home diari subject month episod percent treatment recombin factor viii project annual consumpt recombin factor viii similar plasma-deriv factor viii concentr twenty-six subject recombin factor viii surgic procedur seriou hemorrhag hemostasi excel case De novo format inhibitor subject inhibitor antibodi children low level equal bethesda unit treatment recombin factor viii evid new format antibodi foreign protein recombin factor viii conclus recombin factor viii activ compar plasma factor viii safe efficaci treatment hemophilia